期刊文献+

缺血修饰白蛋白在急性肺栓塞诊断中的作用 被引量:15

The application of ischemia modified albumin in the diagnosis of acute pulmonary embolism
原文传递
导出
摘要 目的:探讨血浆缺血修饰白蛋白对急性肺栓塞(APE)的诊断价值。方法:检测39例确诊为APE患者及对照组30例健康受试者血浆缺血修饰白蛋白(IMA)、D-二聚体含量,利用ROC曲线分析并比较IMA、D-二聚体对APE的诊断价值。结果:APE组患者血浆IMA(75.84±15.70U/ml)、D-二聚体(5.41±5.29mg/L)较对照组明显增高(P<0.01),根据ROC曲线,IMA最佳界值为63.30U/ml,此时诊断APE的敏感性为87.2%,特异性为80%。D-二聚体最佳界值为0.57mg/L,此时诊断APE的敏感性为94.9%,特异性为66.7%。联合IMA、D-二聚体可提高诊断APE的特异性至90%(P<0.05)。IMA在APE高危、中危、低危各亚组之间差异有统计学意(P<0.05或0.01)。结论:IMA可用为APE的诊断标志物,检测IMA水平有助于APE的危险分层。 Objective:To estimate the value of ischemia modified albumin(IMA)in the diagnosis of acute pulmonary embolism(APE).Method:The levels of plasmid IMA and D-Dimer in 39patients with APE and 30healthy controls were measured.The cut-off values of IMA and D-Dimer in the diagnosis of APE were established with ROC Curves.Result:The levels of IMA([75.84±15.70]U/ml)and D-Dimer([5.41±5.29]mg/l)in patients with APE were significantly higher than that in healthy controls(P0.01).According to the ROC curve,the most appropriate IMA cut-off value in APE was 63.30U/ml(with sensitivity 87.2%,specificity 80%).The most appropriate D-Dimer cut-off value in APE was 0.57mg/L(with sensitivity 94.9%,specificity 66.7%).The use of IMA in combination with D-Dimer have a positive impact on the specificity value(P0.05).The level of plasmid IMA in high risk group of APE was higher significantly than that in medium or low risk groups(P 0.05).Conclusion:IMA can be used in diagnosis and evaluation the risk stratification of acute pulmonary embolism.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2010年第9期670-672,共3页 Journal of Clinical Cardiology
基金 江西省卫生厅科技计划(No:20081025)
关键词 急性肺栓塞 缺血修饰白蛋白 D-二聚体 acute pulmonary embolism ischemia modified albumin D-dimer
  • 相关文献

参考文献10

  • 1MANTILLA C B,HORLOCKER T T,SCHROEDER D R,et al.Frequency of myocardial infarction,pulmonary embolism,deep venous thrombosis,and death following primary hip or knee arthroplasty[J].Anesthesiology,2002,96:1140-1146.
  • 2朱振华,颜彦,王齐兵,王翔飞,钱菊英,葛均波.缺血修饰白蛋白在诊断急性心肌缺血中的作用[J].复旦学报(医学版),2009,36(5):625-629. 被引量:9
  • 3ADAM T,ARNAUD P.Guidelines on the diagnosis and management of acute pulmonary embolism:the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology (ESC)[J].Eur Heart J,2008,29:2276-2315.
  • 4BAR-OR D,CURTIS G,RAO N,et al.Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin.An insight into the mechanism of a new assay for myocardial ischemia[J].Eur J Biochem,2001,268:42-47.
  • 5APPLE F S,QUIST H,OTTO A P,et al.Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathonrace[J].Clin Chem,2002,48:1097-1100.
  • 6TUREDI S,PATAN T,GUNDUZ A,et al.Ischemia-modified albumin in the diagnosis of pulmonary embolism:an experimental study[J].Am J Emerg Med,2009,27:635-640.
  • 7KUCHER N,GOLDHABER S Z.Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism[J].Circulation,2003,108:2191-2194.
  • 8DUARTE M M,ROCHA J B,MORESCO R N,et al.Association between ischemia-modified albumin,lipids and inflammation biomarkers in patients with hypercholesterolemia[J].Clin Biochem,2009,42:666-671.
  • 9KAEFER M,PIVA S J,DE CARVALHO J A,et al.Association between ischemia modified albumin,inflammation and hyperglycemia in type 2 diabetes mellitus[J].Clin Biochem,2010,43:450-454.
  • 10王淑红,刘建敏,金培印,申娟,韩勤甫,贾银明.急性肺栓塞患者危险分层的生物学指标[J].临床心血管病杂志,2009,25(9):680-682. 被引量:12

二级参考文献11

  • 1苏建友,鞠少卿,王惠民,王跃国,朱健华,陈莲英,曹金德,倪隽,尚庆毅.白蛋白钴结合试验测定缺血修饰白蛋白[J].中国交通医学杂志,2005,19(3):210-211. 被引量:23
  • 2谷国强,崔炜.急性肺栓塞患者危险分层的生物学指标[J].国际心血管病杂志,2006,33(2):110-113. 被引量:22
  • 3邵亮,李南方.脑利钠肽在临床心血管疾病中的应用进展[J].临床心血管病杂志,2007,23(3):164-166. 被引量:15
  • 4TORBICKI A, PERRIER A, KONSTANTINIDES S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2008, 29:2276 -- 2315.
  • 5GIANNITSIS E, KATUS H A. Risk Stratification in pulmonary embolism based on biomarkers and echocardiography[J].Circulation, 2005, 112: 1520 -- 1521.
  • 6KOSTRUBIEC M, KACZYNSKA A, PRUSZCZYK P. Risk assessment in acute pulmonary embolism[J]. Eur Heart J, 2006, 27:1384 - 1384.
  • 7BECATTINI C, VEDOVATI M C, AGNELLI G Prognostic value of troponins in acute pulmonary em bolism., a meta-analysis[J].Circulation, 2007, 116 427-433.
  • 8VECCHIA L, OTTANI F, FAVERO L, et al. Increased cardiac troponin I on admission predicts inhospital mortality in acute pulmonary embolism[J].Heart, 2004, 90:633 -- 637.
  • 9KRUGER S, GRAF J, MERX M W, et al, Brain natriuretic peptide predicts right failure in peptide predicts right heart failure in patients with acute pulmonaryembolism[J].Am Heart J, 2004, 147:60-65.
  • 10TULEVSKI I I, TEN WOLDE M, VAN VELDHUISEN D J, et, al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism[J]. Int J Cardiol, 2007, 116:161--166.

共引文献19

同被引文献189

引证文献15

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部